At a glance

ClinicalIndex Comparison Record

N/ACompleted· 55 enrolled

Drug / intervention

Pharmacotherapy Managementother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02222181

NCT02222181N/ACompleted

Compare CT.gov

Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease

Universidade Estadual Paulista Júlio de Mesquita Filho·interventional·Posted Aug 21, 2014·Updated May 6, 2016

In Brief

A clinical study evaluating Pharmacotherapy Management for Alzheimer's Disease. Completed, enrolled 55 participants across 1 site.

Detailed Summary

In Brazil, patients with Alzheimer's disease (AD) receiving free drugs of government. Even having access to, little is known about the effectiveness, safety and adherence of drug therapy in this group of patients. The research aims to promote adherence and develop strategies to address Drug-Related Problems (DRP's) in AD patients elderly of reference centre for the Elderly of Araraquara. The clinical parameters will be assessed at the beginning and after the educational intervention period from April 2014 to April 2015.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsAlzheimer's Disease

CountriesBrazil

CollaboratorsFundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Timeline

N/ACompletedFinished

2014201520162017201820192020202120222023202420252026

Enrollment StartApr 2014

First PostedAug 2014

Primary CompletionFeb 2016

Study CompletionMar 2016

TodayJul 2026

First PostedAug 21, 2014

Enrollment StartApr 1, 2014

Primary CompletionFeb 1, 2016

Study CompletionMar 1, 2016

TodayJul 2, 2026

Enrollment to primary: 1.8 yearsPosted 11.9 years ago

Interventions

Pharmacotherapy Managementother

* assessment of patient characteristics as alcoholic, smoker, food, drugs * Pharmacotherapy follow-up * to evaluated medication adherence * Assessment of the individual clinical parameters each patient at baseline and after the educational or pharmacy intervention.